Directory
Price Comparisons
Pharmaceutical Sales
Chantix
ADD/ADHD Drugs
AIDS Drugs
Lunesta, Ambien, Sonata Rozerem
Antidepressants

Antihistamines
ARB's
Arthritis Drugs
Atypical Antipsychotics
Cholesterol Drugs
Cialis
Crestor
Diabetes Drugs
Diabetic Supplies
Drug Information Databases
Enzyte
Lamisil
Levitra
Osteoporosis Drugs
Ortho Evra Lawsuit
Pharmaceutical Sales
Pharmacy CE
Strattera
Tramadol
 
Valtrex
Viagra
Vioxx Trial
Whistleblower Law
Xenical
Zyprexa Lawsuit
Investigations
Enzyte
Zestra
Antibiotics without a prescription
Research/Regulatory
SEARCH Medline
Medline Plus  by Topic
Amedeo
CDER LIst - (FDA)
New Drugs (Center Watch)
FDA
Gen Info;Site Dissection
Boiler Plate Patient Info
Advisory Documents
Drugs@FDA [gateway]
Drug Approvals Report

Newly filed ANDA's
Product Data Database
Orange Book
Upcoming Meetings

Medwatch Safety
Recalls/Alerts

Warning Letters
Medwatch 

Medical Abbreviations
Search By Abbreviation
Search By Definition
www.medilexicon.com

Internet Drug News'

Content Solutions Since 1999

You say "Jump".
We say "How High?"
We will customize the data any way you like. 
Keep our witty headlines or we can tone them down or remove them.

Feature: We can customize our harvest to match what you market.
Benefit: Your reps will be well informed regarding breaking clinical developments
and your competition's tactics.

Feature: Our index is unbranded. People will think you harvested the data yourself.
Benefit: You save time and money; blend the data seamlessly into your intranet.

Give your visitors a reason to visit your site again and again - put our news on your site.

Our
Pharmaceutical News Harvest is in a class of its own.  It is the only pharmacist edited pharmaceutical news information product on the internet. 

The update appears on your site every week-day automatically - you don't have to lift a finger!  Or, if you prefer, we can send you the html each day by e-mail.  All you do is cut-and-paste.

Choose from 2 options:

-
Pharmaceutical News Harvest ; Published daily.
-
Pharmaceutical News Week-in-Review ™; Published weekly.

Each day, our human editors search the web for pharmaceutical news and information.  We sort through thousands of stories and press releases.  We screen out the fluff and index the stories that our target audience finds interesting.

If you would like to license
Pharmaceutical News Harvest or any of our other content, please contact the webmaster for more information regarding our rates.

All of our information products come with an unconditional Money-Back Guarantee if you are less than 100% satisfied. 

Here is what the news looks like in a
10pt Verdana, White Background, Bold Bullet Statements

Please Note:  Some of the links below might not be active  - this page is here just so that you can get an idea of what the Pharmaceutical News Harvest(R) might look like on your site.

9/7
90-Day Pain Narcotic Prescriptions Under Consideration; 30-day limit up till now could go bye-bye:
Feds May Ease Limit on Painkillers … People taking Oxycontin, codeine and other powerful painkillers for chronic pain could get a 90-day supply, under a proposal Wednesday that would let patients avoid repeated doctor visits to get more than 30-day prescriptions…[ AP/Newsday; Hope Yen]

9/7
Feds Say No Flu Shot Shortage This Year
No wait expected for flu shots this year … more than 100 million doses are expected over the next several months… In 2004, production problems at one manufacturer caused severe shortages and hours-long lines for shots. Last September, tight supplies caused doctors to limit shots at first …[ AP/Yahoo; MIKE STOBBE]

9/7
GSK Wins EU Reimportation Decision
GSK gets positive decision in parallel trade case … favourable decision in a long-running dispute over its decision to limit supplies of three drugs to Greece to prevent them being sold cheaply elsewhere in Europe…. [ Reuters ]

9/7
Fragmin Wider Use Gets Green-lighted
US panel backs Pfizer drug for cancer patients …  Japan's Eisai Co Ltd. owns the rights to promote Fragmin in the United States … Fragmin effectively prevents blood clots in cancer patients and warrants wider approval… [ Reuters; Susan Heavey]

9/7
FDA Panel Torpedoes Leukemia Drug Genasense
FDA Panel Votes Against Leukemia Drug …  reviewers said that more leukemia patients responded to chemotherapy when the Genasense is added to their treatment mix, but cautioned that the overall difference is of "questionable clinical significance…[ AP/Newsday ]
US experts reject Genta drug for blood cancer … chronic lymphocytic leukemia (CLL) responded to chemotherapy when Genasense was added, it did not extend survival or the time it took for the leukemia to advance… [ Reuters; Susan Heavey]

9/7
Vioxx Plaintiff Lawyer Excoriates Merck's
internal Vioxx investigation:
Merck Handled Vioxx `With Integrity,' Study Concludes …  findings are bogus,'' said plaintiff's attorney Mark Lanier, who won a $253 million verdict against Merck in a Vioxx case last year. ``This was clearly orchestrated for the stock analysts. It's bought and paid for. The firm that did it, which is a notorious anti-plaintiffs' firm, claims to be independent…[ Bloomberg;  David Voreacos and Angela Zimm]
Merck board-requested probe backs it on Vioxx … 20-month review of the drug company's conduct concluded Merck management "acted with integrity" in the development and marketing of Vioxx … report found no member of Merck management tried to mislead scientists or consumers… [ Reuters; Lewis Krauskopf]
See Also> MULTIMEDIA [Video presentation via Wall Street Journal]
See Also> Click Here for actual report [from Wall Street Journal]

9/7
Mylan Wins Ditropan XL Patent Battle
US court backs Mylan on generic incontinence drug … upheld the decision by the U.S. District Court for the Northern District of West Virginia that Mylan's unique delivery system for the generic version of Ditropan XL did not infringe Alza's patent and declared the patent invalid…. [ Reuters ]

9/7
Glaxo's DPT Vaccine Factory Comes Online This Week
Glaxo to open 100 mln euro Hungary vaccine unit ...will be one of Europe's most advanced biotechnology plants and it will manufacture two types of vaccines … plans to manufacture DPT … [ Reuters ]


**************************************************************

Here is what the news looks like in a 9pt Verdana format :

[Please Note
:  Some of the links below might not be active  - this page is here just so that you can get an idea of what the Pharmaceutical News Harvest(R) might look like on your site]

9/7 90-Day Pain Narcotic Prescriptions Under Consideration; 30-day limit up till now could go bye-bye:
Feds May Ease Limit on Painkillers … People taking Oxycontin, codeine and other powerful painkillers for chronic pain could get a 90-day supply, under a proposal Wednesday that would let patients avoid repeated doctor visits to get more than 30-day prescriptions…[ AP/Newsday; Hope Yen]

9/7
Feds Say No Flu Shot Shortage This Year
No wait expected for flu shots this year … more than 100 million doses are expected over the next several months… In 2004, production problems at one manufacturer caused severe shortages and hours-long lines for shots. Last September, tight supplies caused doctors to limit shots at first …[ AP/Yahoo; MIKE STOBBE]

9/7
GSK Wins EU Reimportation Decision
GSK gets positive decision in parallel trade case … favourable decision in a long-running dispute over its decision to limit supplies of three drugs to Greece to prevent them being sold cheaply elsewhere in Europe…. [ Reuters ]

9/7
Fragmin Wider Use Gets Green-lighted
US panel backs Pfizer drug for cancer patients …  Japan's Eisai Co Ltd. owns the rights to promote Fragmin in the United States … Fragmin effectively prevents blood clots in cancer patients and warrants wider approval… [ Reuters; Susan Heavey]

9/7
FDA Panel Torpedoes Leukemia Drug Genasense
FDA Panel Votes Against Leukemia Drug …  reviewers said that more leukemia patients responded to chemotherapy when the Genasense is added to their treatment mix, but cautioned that the overall difference is of "questionable clinical significance…[ AP/Newsday ]
US experts reject Genta drug for blood cancer … chronic lymphocytic leukemia (CLL) responded to chemotherapy when Genasense was added, it did not extend survival or the time it took for the leukemia to advance… [ Reuters; Susan Heavey]

9/7
Vioxx Plaintiff Lawyer Excoriates Merck's
internal Vioxx investigation:
Merck Handled Vioxx `With Integrity,' Study Concludes …  findings are bogus,'' said plaintiff's attorney Mark Lanier, who won a $253 million verdict against Merck in a Vioxx case last year. ``This was clearly orchestrated for the stock analysts. It's bought and paid for. The firm that did it, which is a notorious anti-plaintiffs' firm, claims to be independent…[ Bloomberg;  David Voreacos and Angela Zimm]
Merck board-requested probe backs it on Vioxx … 20-month review of the drug company's conduct concluded Merck management "acted with integrity" in the development and marketing of Vioxx … report found no member of Merck management tried to mislead scientists or consumers… [ Reuters; Lewis Krauskopf]
See Also> MULTIMEDIA [Video presentation via Wall Street Journal]
See Also> Click Here for actual report [from Wall Street Journal]

9/7
Mylan Wins Ditropan XL Patent Battle
US court backs Mylan on generic incontinence drug … upheld the decision by the U.S. District Court for the Northern District of West Virginia that Mylan's unique delivery system for the generic version of Ditropan XL did not infringe Alza's patent and declared the patent invalid…. [ Reuters ]

9/7
Glaxo's DPT Vaccine Factory Comes Online This Week
Glaxo to open 100 mln euro Hungary vaccine unit ...will be one of Europe's most advanced biotechnology plants and it will manufacture two types of vaccines … plans to manufacture DPT… [ Reuters ]

See Also > Our Mission Statement


Questions? please e-mail the webmaster or call 516.242.2957 to leave a voicemail; we will return your call ASAP.

Click Here To Return To Home Page


Who is Corey Nahman? / Our Mission Statement / Advertise / Contact


Site Directory:

Price Comparisons:
Abilify/Actos /Actonel/Acyclovir/Adipex/Adderal/Advicor/Aldara/Allegra /Altovis/Amaryl /Ambien/Amitriptyline /Atacand/Atacand HCT/Avandia /Avandamet/
Avapro, Avalide /Avlimil/Benicar/Bextra/Byetta/Celebrex/ Celexa /Cialis/
Clarinrex/Clozaril/Clozapine/Colestid/Concerta/Condylox/Cozaar/Crestor/
Cymbalta /Denavir/Diovan/ Effexor XR /Effexor /Enzyte/ Evista/Famvir/Flonase /Fluoxetine /Focalin/Fosamax/Geodon/Glipizide/ Glucophage / Glucovance / Hyzaar/
Lamisil/Lescol/Levitra/ Lexapro /Lipitor/Lovastatin/Lunesta/ Metadate
CD/Metformin /Methylphenidate/Methylin/ MetroGel /Micardis /Mobic/ Nasacort/Nasonex/Nexium/Niaspan/Paxil / Plavix /Pravachol/ Prevacid/Propecia/Prozac,Generic Prozac /Questran/Retin-A /Renova /Risperdal/Ritalin/Seroquel/ Singulair /Soma/Sonata/Strattera/Tamiflu/Teveten /Tramadol/Tricor/Valtrex/Viagra/Valium/Vytorin/Welchol/Wellbutrin/Xanax/Xyzal/Zetia/Zocor/Zoloft/Zyban/Zyprexa/Zyrtec

Basics:
Who is Corey Nahman? / Our Mission Statement / Advertise / Contact

Drug Information Databases:
Angiotensin Receptor Blockers (ARBS) / Antidepressants /
Antihistamines /Arthritis Drugs/Atypical Antipsychotics/
Cholesterol Drugs/Diabetes Drugs /ADD, ADHD/Drug Information
Databases; Catalogue of /Drugs For HIV, AIDS / Insulin /
Osteoporosis Drugs/Sleeping Pills

Pharmaceutical Law:
Baycol/Risperdal/Zyprexa/Seroquel Lawsuit/Ortho Evra Lawsuit/
Vioxx Trial Lawsuit/Whistleblower Law/

Drug Information:
Alimta/Avlimil/Altovis/Baycol/Benicar/Cialis/Crestor/Enzyte/Lamisil/
Levitra/Paxil CR /Phentermine/Strattera/Tamiflu/Valtrex/Viagra/
Zestra

Pharmacy:
How To Become A Pharmacist/ Pharmacist Continuing Education/Pharmacy Journals /

Misc:
Cancer Information /Classified/ Diabetes / Diabetic Supplies/
Drug Company Database/ ENT /FDA; Drug Approval Process  /
Heart Disease /HIV AIDS / Medical Information Databases/
Medical Journals/ Paxil CR Alternatives/Pharmaceutical Advertising, Pharmaceutical Marketing  Help Wanted/Medical Information/

Pharmaceutical sales:

Mother Page; Starting Point / Case Study 1Case Study 2 / Case Study 3 / Tips on how to get in / FAQ Table of contents / Willing to relocate / Hardest part of being a rep / How do I know it is right for me? / Working with a recruiter / Typical length of job search / Interview bring with materials / Ride along / Cover Letter / Resume essentials / Small company versus large company; working for / Am I too old / Scientific degree / MBA / Number of calls per day / Cover Letters / Salary and bonus / Getting laid off / Best way to find job / Newspaper advertisements / Trouble getting business cards / Interviews but no offers / Training / Contract rep / Future sales reps / More than one job offer / Resume essentials / How to find a resume writer / Job fairs(A) /Job fairs(B) / So many interviews



Note To Visitors:

We never answer drug or health related questions so please don't e-mail us with your drug related questions.

If you have a question about a drug that you are taking or if you think you are experiencing a side effect from a drug that you are taking you must get in touch with the doctor who prescribed the drug or the pharmacist who dispensed it to you,
not us.

The information contained on this web site is for your information only.  You should never take a drug without a doctor's prescription.   Do NOT give yourself any drug unless it has been prescribed for you by a doctor.

It's foolish to start taking a medicine or stop taking a medicine on your own based on information you read here or any other internet web site because this could cause you to become seriously ill or die or worse even.

Questions or feedback regarding this site?  Contact Webmaster

Read Our Plain-English Privacy Policy


Copyright, 2008 Internet Drug News Inc - all rights reserved
CoreyNahman.com and Pharmaceutical News Harvest are registered Trademarks of Internet Drug News Inc.


*****************************************
We subscribe to The HONcode of  online conduct:

1.  Qualification of author(s)
This site is published and webmastered by Corey Nahman, Registered pharmacist in the Sate of New York.
2. 
Complementarity
Let it be known that the information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
3. 
Privacy.
We respect the privacy of the users of this site.  Please see our plain English privacy policy.
4.
Attribution
At all times, the information on this site shall be footnoted with the source(s) of published information, date and medical and health pages provided.
5. 
Justifiability
This site shall at all times back up claims relating to benefits and performance.
Transparency
This site shall at all times use accessible presentation, you can e-mail the publisher of this site at his personal e-mail address at any time.
7. 
Financial disclosure
This site is supported by click advertisements, banner advertisements and affiliate arrangements.  All ads are properly labeled as such.  If you have any questions regarding how we make money please e-mail the webmaster with your questions.  All advertisements shall be clearly distinguished from content.

*********************************************
Proudly Published In NEW YORK CITY, USA

Site Map |
Privacy Policy | Contact Webmaster |
Site Mission Statement, Intended Audience, Editorial Policy, Advertising Policy
This Page Last Updated 8/22/2008